Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)

This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic

Saved in:

Bibliographic Details
Published in	Journal of cancer research and clinical oncology Vol. 146; no. 11; pp. 3075 - 3078
Main Authors	Ivanyi, Philipp, Grüllich, Carsten, Kroeger, Nils, Gauler, Thomas, Johannsen, Manfred, Bedke, Jens, Grünwald, Viktor
Format	Journal Article
Language	English
Published	Berlin/Heidelberg Springer Berlin Heidelberg 01.11.2020
Subjects	Antineoplastic Agents - therapeutic use Betacoronavirus Cancer Research Carcinoma, Renal Cell - drug therapy Coronavirus Infections COVID-19 Hematology Humans Internal Medicine Kidney Neoplasms - drug therapy Letter to the Editor Medicine Medicine & Public Health Oncology Pandemics Pneumonia, Viral Practice Guidelines as Topic SARS-CoV-2
Online Access	Get full text

Cover

Loading…

Abstract	This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic
AbstractList	This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic. Abstract This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic
Author	Gauler, Thomas Grünwald, Viktor Bedke, Jens Johannsen, Manfred Kroeger, Nils Grüllich, Carsten Ivanyi, Philipp
Author_xml	– sequence: 1 givenname: Philipp surname: Ivanyi fullname: Ivanyi, Philipp organization: Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Immunonclogical COoperative Group (ICOG) of the Comprehensive Cancer Center Lower Saxoney, Hannover (CCC-N) – sequence: 2 givenname: Carsten surname: Grüllich fullname: Grüllich, Carsten organization: Genitourinary Oncology, Department of Urology, University Hospital Dresden – sequence: 3 givenname: Nils surname: Kroeger fullname: Kroeger, Nils organization: Department of Urology, University Medicine Greifswald, Urologie-Altstadtquartier Magdeburg – sequence: 4 givenname: Thomas surname: Gauler fullname: Gauler, Thomas organization: Department of Radiation Oncology, West German Cancer Center, University Hospital Essen of the University Duisburg-Essen – sequence: 5 givenname: Manfred surname: Johannsen fullname: Johannsen, Manfred organization: Urology and Urooncology Practice Berlin, Vice Chairman d-uo (Deutsche Uro-Onkologen) – sequence: 6 givenname: Jens orcidid: 0000-0003-2778-3108 surname: Bedke fullname: Bedke, Jens email: jens.bedke@med.uni-tuebingen.de organization: Department of Urology, Eberhard Karls University Tuebingen – sequence: 7 givenname: Viktor surname: Grünwald fullname: Grünwald, Viktor email: viktor.gruenwald@uk-essen.de organization: Interdisciplinary Genitourinary Oncology, West-German Cancer Center Essen Clinic for Medical Oncology and Clinic for Urology OZ1, University Hospital Essen (AöR)
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/32816108$$D View this record in MEDLINE/PubMed
BookMark	eNp9UctuEzEUtVARTQs_wAJ5WRamfs2LBVIU0VKpAokAW8vx3EldZuzB9pT2y_g9PEmoYMPGlu89j-t7TtCR8w4QesnoG0ZpdR4plYITyimhQkhG5BO0YHOJCVEcoQVlFSMFZ-UxOonxluZ3UfFn6FjwmpWM1gv0a_0QEwzW4BRApwFcwr7Dur3TzkB7PkDSMemUAQGc7rGBPh86GOv8oLF1ON0ANt4luN9R18vPa7Ly3wjHo3btrP02c40fsniblbyLuAt-2BFt5oXWRmPH3jodHvBPH75bt8Xb4KcRdz4cjNM0-BDx2dXyknx8_Rw97XQf4cXhPkVfL95_WX0g158ur1bLa2KkLBOpDKsobzVrZA1dUUlRGmakoIxyQeWGgyh1s2m7st3whrGuKGpeMcmk7DiAFKfo3V53nDYDtCbvJ-hejcEOeVjltVX_dpy9UVt_p7JVLZoqC5wdBIL_MUFMasi_zUvUDvwUFZeiqIqykbMX30NN8DEG6B5tGFVz4mqfuMqJq13iaia9-nvAR8qfiDNA7AExt9wWgrr1U8gbjf-T_Q3T_rvP
CitedBy_id	crossref_primary_10_1055_a_1579_0562 crossref_primary_10_1055_a_2114_5952 crossref_primary_10_3233_KCA_210112 crossref_primary_10_1186_s13045_021_01205_z
Cites_doi	10.1016/j.ejca.2018.02.012 10.1001/jamaoncol.2018.3923 10.1016/j.annonc.2020.04.010 10.1016/S1470-2045(20)30096-6 10.1093/annonc/mdz056 10.2217/imt-2020-0067 10.1200/JCO.2016.68.2005 10.1016/j.annonc.2020.03.296 10.1038/s41571-020-0362-6 10.1136/jitc-2020-000891 10.1038/s41591-018-0053-3 10.1200/GO.20.00097 10.1101/2020.05.27.20083287 10.1002/pbc.26642 10.1002/jmv.25972
ContentType	Journal Article
Copyright	The Author(s) 2020
Copyright_xml	– notice: The Author(s) 2020
CorporateAuthor	Interdisciplinary working group on renal tumors (IAG-N) of the German Cancer Socity (DKG) On behalf of the Interdisciplinary working group on renal tumors (IAG-N) of the German Cancer Socity (DKG)
CorporateAuthor_xml	– name: Interdisciplinary working group on renal tumors (IAG-N) of the German Cancer Socity (DKG) – name: On behalf of the Interdisciplinary working group on renal tumors (IAG-N) of the German Cancer Socity (DKG)
DBID	C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM
DOI	10.1007/s00432-020-03341-4
DatabaseName	Springer_OA刊 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic CrossRef
Database_xml	– sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1432-1335
EndPage	3078
ExternalDocumentID	10_1007_s00432_020_03341_4 32816108
Genre	Letter Correspondence
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C -~X .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYOK AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABPTK ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHVE ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AEQTP AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFFNX AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI C6C CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GUQSH GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z7W Z7X Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAEOY AAJBT AAKKN ABAKF ABEEZ ACACY ACULB ACZOJ AEFQL AFBBN AGQEE AGRTI CGR CUY CVF ECM EIF NPM AAYXX AFGXO AJOOF ALIPV C24 CITATION H13 7X8 5PM
ID	FETCH-LOGICAL-c446t-7c1702da1948ef57436c1c430102304b2e36a9bdf6db2911f5582714144f2ee43
IEDL.DBID	C6C
ISSN	0171-5216
IngestDate	Tue Sep 17 20:53:17 EDT 2024 Sat Aug 17 05:20:23 EDT 2024 Thu Sep 12 17:29:38 EDT 2024 Thu May 23 23:25:43 EDT 2024 Sat Dec 16 12:01:09 EST 2023
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	11
Language	English
License	Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c446t-7c1702da1948ef57436c1c430102304b2e36a9bdf6db2911f5582714144f2ee43
Notes	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ORCID	0000-0003-2778-3108
OpenAccessLink	https://doi.org/10.1007/s00432-020-03341-4
PMID	32816108
PQID	2435756944
PQPubID	23479
PageCount	4
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_7438397 proquest_miscellaneous_2435756944 crossref_primary_10_1007_s00432_020_03341_4 pubmed_primary_32816108 springer_journals_10_1007_s00432_020_03341_4
PublicationCentury	2000
PublicationDate	2020-11-01
PublicationDateYYYYMMDD	2020-11-01
PublicationDate_xml	– month: 11 year: 2020 text: 2020-11-01 day: 01
PublicationDecade	2020
PublicationPlace	Berlin/Heidelberg
PublicationPlace_xml	– name: Berlin/Heidelberg – name: Germany
PublicationTitle	Journal of cancer research and clinical oncology
PublicationTitleAbbrev	J Cancer Res Clin Oncol
PublicationTitleAlternate	J Cancer Res Clin Oncol
PublicationYear	2020
Publisher	Springer Berlin Heidelberg
Publisher_xml	– name: Springer Berlin Heidelberg
References	Jones, Neal, Duffy, Scott, Whitaker, Brain (CR7) 2020; 2045 Motzer, Escudier, McDermott, Arén Frontera, Melichar, Powles (CR12) 2020; 8 Wang, Salem, Cohen, Chandra, Menzer, Ye (CR14) 2018; 4 Liang, Guan, Chen, Wang, Li, Xu (CR9) 2020; 21 CR8 CR17 Choueiri, Motzer, Rini, Haanen, Campbell, Venugopal (CR3) 2020; 31 CR15 Bersanelli (CR1) 2020; 12 CR13 Hanna, Evans, Booth (CR6) 2020; 17 Zhang, Zhu, Xie, Wang, Wang, Chen (CR16) 2020; 31 McDermott, Huseni, Atkins, Motzer, Rini, Escudier (CR10) 2018; 24 Choueiri, Hessel, Halabi, Sanford, Michaelson, Hahn (CR2) 2018; 94 Escudier, Porta, Schmidinger, Rioux-Leclercq, Bex, Khoo (CR5) 2019; 30 Naidoo, Wang, Woo, Iyriboz, Halpenny, Cunningham (CR11) 2017; 35 Desai, Sachdeva, Parekh, Desai (CR4) 2020; 6 D Jones (3341_CR7) 2020; 2045 TK Choueiri (3341_CR2) 2018; 94 A Desai (3341_CR4) 2020; 6 W Liang (3341_CR9) 2020; 21 M Bersanelli (3341_CR1) 2020; 12 TP Hanna (3341_CR6) 2020; 17 3341_CR13 3341_CR15 RJ Motzer (3341_CR12) 2020; 8 3341_CR17 TK Choueiri (3341_CR3) 2020; 31 3341_CR8 L Zhang (3341_CR16) 2020; 31 J Naidoo (3341_CR11) 2017; 35 B Escudier (3341_CR5) 2019; 30 DY Wang (3341_CR14) 2018; 4 DF McDermott (3341_CR10) 2018; 24
References_xml	– volume: 94 start-page: 115 year: 2018 end-page: 125 ident: CR2 article-title: Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): PROGRESSION-free survival by independent review and overall survival update publication-title: Eur J Cancer [Internet] doi: 10.1016/j.ejca.2018.02.012 contributor: fullname: Hahn – volume: 2045 start-page: 19 issue: 20 year: 2020 end-page: 20 ident: CR7 article-title: Comment Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer : the view from primary care publication-title: Lancet Oncol [Internet] contributor: fullname: Brain – volume: 4 start-page: 1721 issue: 12 year: 2018 end-page: 1728 ident: CR14 article-title: Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.3923 contributor: fullname: Ye – volume: 31 start-page: 1030 issue: 8 year: 2020 end-page: 1039 ident: CR3 article-title: Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma publication-title: Ann Oncol. doi: 10.1016/j.annonc.2020.04.010 contributor: fullname: Venugopal – volume: 21 start-page: 335 issue: 3 year: 2020 end-page: 337 ident: CR9 article-title: Cancer patients in SARS-CoV-2 infection a nationwide analysis in China publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(20)30096-6 contributor: fullname: Xu – ident: CR15 – volume: 30 start-page: 706 issue: 5 year: 2019 end-page: 720 ident: CR5 article-title: Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol [Internet] doi: 10.1093/annonc/mdz056 contributor: fullname: Khoo – volume: 12 start-page: 269 issue: 5 year: 2020 end-page: 273 ident: CR1 article-title: Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors publication-title: Immunotherapy. doi: 10.2217/imt-2020-0067 contributor: fullname: Bersanelli – ident: CR17 – ident: CR13 – volume: 35 start-page: 709 issue: 7 year: 2017 end-page: 717 ident: CR11 article-title: Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy publication-title: J Clin Oncol doi: 10.1200/JCO.2016.68.2005 contributor: fullname: Cunningham – volume: 31 start-page: 894 issue: 7 year: 2020 end-page: 901 ident: CR16 article-title: Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan publication-title: China. Annal oncol doi: 10.1016/j.annonc.2020.03.296 contributor: fullname: Chen – volume: 17 start-page: 268 issue: 5 year: 2020 end-page: 270 ident: CR6 article-title: Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-0362-6 contributor: fullname: Booth – volume: 8 start-page: e000891 issue: 2 year: 2020 ident: CR12 article-title: Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial publication-title: J Immunother Cancer doi: 10.1136/jitc-2020-000891 contributor: fullname: Powles – ident: CR8 – volume: 24 start-page: 749 issue: 6 year: 2018 end-page: 757 ident: CR10 article-title: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma publication-title: Nat Med doi: 10.1038/s41591-018-0053-3 contributor: fullname: Escudier – volume: 6 start-page: 557 year: 2020 end-page: 559 ident: CR4 article-title: COVID-19 and cancer: lessons from a pooled meta-analysis publication-title: JCO Glob Oncol doi: 10.1200/GO.20.00097 contributor: fullname: Desai – volume: 8 start-page: e000891 issue: 2 year: 2020 ident: 3341_CR12 publication-title: J Immunother Cancer doi: 10.1136/jitc-2020-000891 contributor: fullname: RJ Motzer – ident: 3341_CR8 doi: 10.1101/2020.05.27.20083287 – volume: 6 start-page: 557 year: 2020 ident: 3341_CR4 publication-title: JCO Glob Oncol doi: 10.1200/GO.20.00097 contributor: fullname: A Desai – volume: 31 start-page: 894 issue: 7 year: 2020 ident: 3341_CR16 publication-title: China. Annal oncol doi: 10.1016/j.annonc.2020.03.296 contributor: fullname: L Zhang – volume: 17 start-page: 268 issue: 5 year: 2020 ident: 3341_CR6 publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-0362-6 contributor: fullname: TP Hanna – ident: 3341_CR13 doi: 10.1002/pbc.26642 – ident: 3341_CR15 doi: 10.1002/jmv.25972 – volume: 24 start-page: 749 issue: 6 year: 2018 ident: 3341_CR10 publication-title: Nat Med doi: 10.1038/s41591-018-0053-3 contributor: fullname: DF McDermott – volume: 35 start-page: 709 issue: 7 year: 2017 ident: 3341_CR11 publication-title: J Clin Oncol doi: 10.1200/JCO.2016.68.2005 contributor: fullname: J Naidoo – volume: 94 start-page: 115 year: 2018 ident: 3341_CR2 publication-title: Eur J Cancer [Internet] doi: 10.1016/j.ejca.2018.02.012 contributor: fullname: TK Choueiri – volume: 4 start-page: 1721 issue: 12 year: 2018 ident: 3341_CR14 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.3923 contributor: fullname: DY Wang – volume: 12 start-page: 269 issue: 5 year: 2020 ident: 3341_CR1 publication-title: Immunotherapy. doi: 10.2217/imt-2020-0067 contributor: fullname: M Bersanelli – volume: 31 start-page: 1030 issue: 8 year: 2020 ident: 3341_CR3 publication-title: Ann Oncol. doi: 10.1016/j.annonc.2020.04.010 contributor: fullname: TK Choueiri – ident: 3341_CR17 – volume: 30 start-page: 706 issue: 5 year: 2019 ident: 3341_CR5 publication-title: Ann Oncol [Internet] doi: 10.1093/annonc/mdz056 contributor: fullname: B Escudier – volume: 2045 start-page: 19 issue: 20 year: 2020 ident: 3341_CR7 publication-title: Lancet Oncol [Internet] contributor: fullname: D Jones – volume: 21 start-page: 335 issue: 3 year: 2020 ident: 3341_CR9 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(20)30096-6 contributor: fullname: W Liang
SSID	ssj0017572
Score	2.3528504
Snippet	This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment... Abstract This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic...
SourceID	pubmedcentral proquest crossref pubmed springer
SourceType	Open Access Repository Aggregation Database Index Database Publisher
StartPage	3075
SubjectTerms	Antineoplastic Agents - therapeutic use Betacoronavirus Cancer Research Carcinoma, Renal Cell - drug therapy Coronavirus Infections COVID-19 Hematology Humans Internal Medicine Kidney Neoplasms - drug therapy Letter to the Editor Medicine Medicine & Public Health Oncology Pandemics Pneumonia, Viral Practice Guidelines as Topic SARS-CoV-2
Title	Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)
URI	https://link.springer.com/article/10.1007/s00432-020-03341-4 https://www.ncbi.nlm.nih.gov/pubmed/32816108 https://search.proquest.com/docview/2435756944 https://pubmed.ncbi.nlm.nih.gov/PMC7438397
Volume	146
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELbYXQlxQctzy6MyEgcQWCS2Yyfc0qjdBbQV2qWonCLHdUQPTVZtqv1p_D1mnDSiuwiJi32IPYkyfnzj8XxDyGsRBCZInGVRZDiTRilmnCoYl8ZqV8KO4K_8n0_V2Ux-nkfzjiYHY2Fu-O892afgDI2cQMCKy-QBOYoApuAkzFTWewx05BM1If0LGFeh6gJk_i5jfxO6hSxvX5C84SX1m8_kmNzvUCNNWzU_IHdc9ZDcPe_84o_Ir5Z4fGlpf3Gc1iXdOfg_rFxjMHQIGqwdSsLzemoxj1BVrwxdVhSAIMV767BYY9fL9OKSZfV3xukVnjOD7I8UrecVCG_zMG0oxqb4jkg6sf4zwJdet4fw1EeNUEDG3Yub7apeb-ibT-kpm759TGaT8bfsjHUpGZgFu7Fh2oY64AsTJjJ2ZQTwQ9nQSoHMdCKQBXdCmaRYlJimCtbRMopirkMJZlvJnZPiCTms6sqdEBoKFWgbaxBZSmvCAqCbgg2V64KbRRAOyLudjvKrlnkj7zmWvUZz0GjuNZrLAXm1U2MOEwT_oqlcvd3kHAChjlQioc3TVq29PMFjGEpBPCB6T-F9AyTf3n9SLX96Em6NHK-JHpD3u6GRd7N_84_PfPZ_zZ-TexyHrY99fEEOm_XWvQQQ1BRDcqDnGso4C4fkKJ2MRlOsT398GUM9Gk-_Xgz9DIFyxtPfGp8GCA
link.rule.ids	230,315,786,790,891,27957,27958,31755,33302,33780,41116,41155,41558,42185,42224,42627,51611,52146,52269
linkProvider	Springer Nature
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BVgIuvB_L00gcQOCSOH4k3FZV2y3t7oF2UTlFjtdRV9Um1SYrJP4Yf4-x8xDbIqSeY0_ieOL5JjPzDcC7KAh0kFhDhdCMci0l1VZmlHFtlM3RIviU_8lUjmf866k4bYvCqi7bvQtJ-pO6L3bz7HHUuTtBhGcv5Tdhi6OFEgPYGu3_ONztowdK-KZNjgoGHa1QtsUy_5ayaZCuoMyryZKXIqbeEO3dg1m3hCb_5Hx7XWfb5tcldsfrrvE-3G2RKRk1qvQAbtjiIdyatLH3R_C7ITdfGNInp5MyJ10SweelrbUrT8IBK-skuZgAMa5XUVEuNVkUBMEmcbnxaBDc1OPRt2O6U36njFy4f9ko-wtxHvoShTe9niri6l_8REdssfq7iJj8bH70E1-ZQhB9tzeu18tyVZH3B6N9Ov3wGGZ7uyc7Y9q2faAGfdOaKhOqgM11mPDY5gIhjjSh4ZFjv4sCnjEbSZ1k89y1wsKzOhciZirk6BrmzFoePYFBURb2GZAwkoEysUKROTc6zBAeSjTaTGVMz4NwCB-7vU8vGnaPtOdx9nuR4l6kfi9SPoS3nXqk-BG6t6gLW66rlCHoVEImHMc8bdSllxexGFF1EA9BbShSP8ARfG9eKRZnnuhbOR7ZRA3hU6ctaXvCVP95zOfXG_4Gbo9PJkfp0cH08AXcYU75fK3lSxjUq7V9haCrzl6339gfV3Mitw
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED7BJk28wPhdGGAkHkDgNXEcO-GtGus2xirE2DSeLMd1RIWaVG0qEP_Y_r2dnR9aN4SEeI5zSeqz_V3vvu8AXkVBoIPUGhrHmlGuhaDaiowyro20OZ4IvuT_aCT2T_jHs_jsEovfV7u3Kcma0-BUmoqqPxvn_Y745pXkqAt9ggj3YcpvwjrHZYs-vj7Y-3a422USZOwbODlZGAy6QtEQZ_5sZfVwuoY4rxdOXsme-kNpeAd0-zl1LcqP7WWVbZvfV5Qe_-d7N-F2g1jJoHaxu3DDFvdg46jJyd-H81r0fGJIV7ROypy0xQX9qa20oy3hgLl1llyugBjXw6gop5pMCoIglPgX-uVvPR58OaY75SllZOb-40bb74mL3KdovO4BtSCOF-NvdIIX88vkYvKzTgAQz1ghiMqbB1fLaTlfkNcHgz06evMAToa7X3f2adMOghqMWSsqTSgDNtZhyhObxwh9hAkNj5wqXhTwjNlI6DQb565FFu7heRwnTIYcQ8acWcujh7BWlIV9DCSMRCBNItFkzo0OM4SNAg9zJjOmx0HYg7etH6hZrfqhOn1nPxcK50L5uVC8By9bV1G4ON2vqAtbLheKIRiVsUg5jnlUu05nL2IJou0g6YFccapugBP-Xr1STL57AXDp9GVT2YN3reeoZudZ_OU1n_zb8Bew8fnDUH06GB0-hVvM-Z6nYG7BWjVf2meIxarsebPcLgAo0yuS
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systemic+treatment+of+advanced%2Fmetastatic+renal+cell+carcinoma+in+the+context+of+SARS-CoV-2+pandemic%3A+recommendations+from+the+interdisciplinary+working+group+for+renal+tumors+%28IAG-N%29&rft.jtitle=Journal+of+cancer+research+and+clinical+oncology&rft.au=Ivanyi%2C+Philipp&rft.au=Gr%C3%BCllich%2C+Carsten&rft.au=Kroeger%2C+Nils&rft.au=Gauler%2C+Thomas&rft.date=2020-11-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0171-5216&rft.eissn=1432-1335&rft.volume=146&rft.issue=11&rft.spage=3075&rft.epage=3078&rft_id=info:doi/10.1007%2Fs00432-020-03341-4&rft_id=info%3Apmid%2F32816108&rft.externalDBID=PMC7438397
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0171-5216&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0171-5216&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0171-5216&client=summon